Traws Pharma, Inc. (TRAW) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Traws Pharma, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.588 -- 00:00:05.913 gentlemen, thank you for standing by. At this 00:00:10.944 -- 00:00:14.950 time, all participants are in a listen-only mode. 00:00:14.950 -- 00:00:20.279 Following management's prepared remarks, we will hold a question and answer session. 00:00:20.279 -- 00:00:25.527 To ask a question at that time, please press star followed by one on your touchtone 00:00:25.527 -- 00:00:30.722 phone. If anyone has difficulty hearing the conference, please press star zero 00:00:30.722 -- 00:00:33.047 for operator assistance. 00:00:33.047 -- 00:00:35.287 As a reminder, 00:00:35.992 -- 00:00:41.098 I would now like to turn the call over to 00:00:41.462 -- 00:00:42.945 Science Advisors. 00:00:42.945 -- 00:00:44.945 Thank 00:00:45.890 -- 00:00:51.200 you, Operator, and welcome everyone to Trust Pharma's full year 2025 financial 00:00:51.200 -- 00:00:53.744 results and business update conference call. 00:00:53.744 -- 00:00:59.289 This afternoon, TRAS issued a press release reporting its 2025 financial results 00:00:59.289 -- 00:01:03.894 and provided a business update. If you have not yet seen this press release, it is available 00:01:03.894 -- 00:01:07.477 in the investor relations section of the company's website. 00:01:07.477 -- 00:01:10.760 Following my introduction, we'll hear from TRAS Chief Executive Officer, Dr. 00:01:10.760 -- 00:01:14.624 Ian Dukes, and Chief Financial Officer, Charles Parker. 00:01:14.624 -- 00:01:18.648 Before we begin, I would like to remind everyone that statements made during this conference 00:01:18.648 -- 00:01:22.796 call will include forward-looking statements under the Safe Harbor provisions of the 00:01:22.796 -- 00:01:26.099 Private Securities Litigation Form Act of 1995, 00:01:26.099 -- 00:01:30.743 which involved...